Infectious diseases testing market includes the detection of diseases caused by microorganisms such as fungi, bacteria, viruses, and parasites are called infectious diseases. These infectious diseases are transmitted from person to person through various routes such as contaminated food, contaminated water, and oro-feacal route, among others. Though there are vaccines to prevent few of the infectious diseases, such as measles and chickenpox, not all infectious diseases have vaccines. Hence it is very necessary to develop testing methods for various infectious diseases. In addition, there have been a range of new infectious diseases in the market which would contribute to the growth of infectious diseases testing market. In addition, the recent advances with the identification of nanoprobes and their utilization in in-vitro diagnostics which lead to the effective detection of infectious diseases through nanodiagnosis, which would revolutionize the infectious diseases testing market. The various applications of nanodiagnosis include identification of biomarkers, and diagnostics of infectious diseases, among others. In infectious diseases testing market, In vitro diagnostics are commonly employed for the detection of infectious diseases, and these tests are performed in various samples, such as blood, urine, serum, and saliva, among others.
Infectious diseases testing market can be segmented on the basis of technology employed for the detection, product type, end user, application, and geography. On the basis of test type, the infectious diseases testing market can be segmented into Immunochemistry testing, microbiology testing, and molecular diagnostics, among others. Immunochemistry testing includes immunoassays such as enzyme linked immunosorbant assay (ELISA), and chemiluminescence immunoassays. Product type segmentation of the infectious diseases detection market can be given as reagents, instruments and software. Infectious diseases detection market can be segmented on the basis of application into hepatitis, sexually transmitted diseases, syphilis, measles, tuberculosis, and malaria, among others. The end users in the infectious diseases detection market include hospitals, point of care centers and diagnostic laboratories. On the basis of geography, infectious diseases testing market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.
The growing prevalence of infectious diseases, the continuous mutations in the microorganisms leading to new strains, and the growing rate of new infections contribute to the growth of the infectious diseases testing market. In addition, the changing technology leading to the development of tests with enhanced detection rate, growing awareness among people contribute positively to the growth of infectious diseases testing market. Growing awareness among people, increasing government initiatives to improve the health profiles of the population and growing geriatric population contribute to the growth in the infectious diseases testing market. Furthermore, growing modes of transmission of the disease such as various zoonotic modes, and the lack of cleanliness in certain regions lead to the growth in the prevalence of infectious diseases contributing to the growth of infectious diseases testing market. However, asymptomatic conditions of infectious diseases, lack of treatment for certain diseases, false positive results with certain tests might hinder the growth of infectious diseases testing market.
Based on the technology type, immunochemistry tests such as immunoassays are expected to dominate the infectious diseases testing market. In addition, the increasing demand for rapid tests, contribute to the growth of infectious diseases testing market. On the basis of product type, reagents that include molecular diagnostic kits and immunoassays employed in the detection of various infectious diseases dominated the infectious diseases testing market and are expected to grow further during the forecast period. On a regional basis, North America dominated to the infectious diseases testing market, owing to its advanced healthcare infrastructure, increased healthcare spending, and focus on development of other tests which give faster and accurate results. However, Asia Pacific is expected to grow at a highest CAGR in the infectious diseases testing market, during the forecast period, owing to the growing prevalence of infectious diseases and the growing government initiatives on enhancing the healthcare infrastructure.
The leading players in infectious diseases testing market include Abbott Laboratories, Alere, Inc., Becton Dickinson (BD) Company, Inc., bioMeriux SA, Bio-Rad Laboratories, Gen-Probe, Inc. (a part of Hologic, Inc.), LifeScan, Inc. (a Johnson & Johnson company), Luminex Corporation, Ortho-Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.